WO2023132120A1 - Method for producing extract, method for producing cosmetic, and method for producing substance for oral use - Google Patents

Method for producing extract, method for producing cosmetic, and method for producing substance for oral use Download PDF

Info

Publication number
WO2023132120A1
WO2023132120A1 PCT/JP2022/040577 JP2022040577W WO2023132120A1 WO 2023132120 A1 WO2023132120 A1 WO 2023132120A1 JP 2022040577 W JP2022040577 W JP 2022040577W WO 2023132120 A1 WO2023132120 A1 WO 2023132120A1
Authority
WO
WIPO (PCT)
Prior art keywords
extract
producing
hot spring
solvent
placenta
Prior art date
Application number
PCT/JP2022/040577
Other languages
French (fr)
Japanese (ja)
Inventor
幸雄 三井
Original Assignee
株式会社ホルス
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社ホルス filed Critical 株式会社ホルス
Publication of WO2023132120A1 publication Critical patent/WO2023132120A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/50Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/51Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/57Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Definitions

  • the present invention relates to a method for producing an extract by adding raw materials to a solvent and extracting useful ingredients, and a method for producing cosmetics or oral products containing the extract.
  • Hot spring water contains ingredients that are good for the skin, so it is often used not only for bathing but also in cosmetics and health foods.
  • Patent Document 1 discloses a cosmetic containing Moor hot spring water, Moor hot spring water, Hakutsuru Reishi mushroom, Hakutsuru Reishi extract, or Hakutsuru Reishi extract powder as main ingredients for the purpose of enhancing skin moisturizing ability.
  • Patent Document 2 discloses that alkaline hot spring water, phenoxyethanol, collagen, elastin, placenta extract, pentylene glycol, glycerin, and butylene glycol are used for the purpose of increasing water retention and moisturizing power. are mixed, and the mixed liquid is alkaline.
  • Placenta extract extracted from placenta which is an organ unique to mammals, contains various useful components such as amino acids and enzymes. Therefore, placenta extract is used as a raw material for cosmetics, health foods, and the like.
  • Rhinophyte extract extracted from umbilical cord, amniotic membrane extract extracted from amniotic membrane, sake lees extract extracted from sake lees, or bird's nest extract extracted from bird's nest are also used as raw materials for cosmetics, health foods, etc.
  • Patent Literature 3 discloses a food for suppressing gray hair containing a placenta extract as an active ingredient.
  • Patent Document 4 discloses a diet food containing a placenta extract and a rhinoceros cypress extract.
  • Patent Document 5 discloses a method for producing an amniotic membrane-derived raw material (amniotic membrane extract) containing many components useful for anti-aging effects.
  • Patent Document 6 discloses a gel cosmetic containing a carboxy group-containing anionic polymer, a compound of hydroxypropylmethylcellulose or xanthan gum, and sake lees extract as a skin-beautifying ingredient.
  • Patent Document 7 discloses a drink containing sialic acid as a bird's nest extract. It is disclosed to be formed as an extract to be extracted and contained in a beverage solvent.
  • Patent Document 8 discloses food and drink containing 4-vinylguaiacol, and in paragraph 0045, one of the waters that can be used as an extraction solvent when extracting 4-vinylguaiacol from plants etc. hot spring water is mentioned.
  • Patent Document 9 discloses an ABCA12 gene expression promoter containing a peony extract as an active ingredient. ing.
  • Patent Documents 1 and 2 when hot spring water is mixed after extraction to form a mixture, the concentration of the extract is diluted, and the amount of useful ingredients contained in the mixture is not necessarily sufficient. There is Moreover, Patent Documents 3 to 7 do not attempt to increase the amount of useful components contained in the extract by using hot spring water. In addition, Patent Documents 8 and 9 state that hot spring water may be used as an extraction solvent, but this is only an example of an extraction solvent, and focusing on hot spring water, the useful components contained in the extract can be extracted. I'm not trying to increase the quantity.
  • the present invention provides a method for producing an extract that uses hot spring water to increase the content of useful components in the extract (extract, extraction solution) compared to the conventional method, thereby enhancing usefulness for the skin, and the method for producing the extract.
  • An object of the present invention is to provide a method for producing cosmetics and oral preparations containing an extract.
  • a method for producing an extract corresponding to claim 1 is characterized in that hot spring water having a pH of 5.5 or more and 8.5 or less is used as a solvent in the extraction step of putting the raw material into a solvent and extracting the useful components of the raw material.
  • the present invention according to claim 2 is characterized in that, in the method for producing an extract according to claim 1, the raw material is placenta, rhinoceros cypress, amniotic membrane, sake lees, or bird's nest.
  • the present invention according to claim 3 is the method for producing an extract according to claim 1, wherein the raw material is placenta, rhinoceros cypress, or amniotic membrane, and a freezing step of freezing the raw material before the extraction step; It is characterized by performing a normal temperature melting step of melting the raw material at normal temperature, a washing step of washing the raw material after the normal temperature melting step, and a mincing process of chopping the raw material after the washing step.
  • the hot spring water is Yugawara hot spring water.
  • the present invention according to claim 5 is the method for producing an extract according to claim 4, wherein the Yugawara hot spring water has a sodium/calcium-chloride/sulfate hot spring and is weakly alkaline.
  • Characterized by A method for producing cosmetics corresponding to claim 6 is characterized in that the extract obtained by the method for producing an extract according to any one of claims 1 to 5 is blended.
  • a method for producing an oral preparation corresponding to claim 7 is characterized by blending an extract obtained by the method for producing an extract according to any one of claims 1 to 5.
  • the content of useful ingredients in the extract can be increased compared to the past, and the usability for the skin can be enhanced.
  • Graph showing the results of component analysis of the same placenta extract Graph showing the results of the same skin moisture content test 1
  • Graph showing the results of component analysis of the Rhinoceros rhinoceros extract Graph showing the results of the same skin moisture content test 3
  • Graph showing the results of component analysis of the same sake lees extract (sake lees extract) Graph showing the results of the same skin moisture content test 5
  • FIG. 1 is a diagram showing the manufacturing process of a placenta extract (placenta extract).
  • placenta extract various animal and plant-derived raw materials such as rhinoceros bream, amniotic membrane, sake lees, or bird's nest can be used.
  • S1 placenta collection step
  • the placentas to be collected may be those of mammals such as humans, pigs, horses or sheep, but healthy pig or horse placentas that are superior in safety and suitable for use in cosmetics and health foods should be selected. is preferred.
  • the collected placenta is immediately frozen (S2: first freezing step).
  • the frozen placenta is transported to a designated location and stored. As a result, the collected placenta can be stored in good condition.
  • the frozen placenta is thawed at room temperature (S3: thawing step).
  • the thawed placenta is washed after removing the membrane tissue (S4: washing step), and the villous tissue is chopped (S5: mincing step).
  • the meat is cut into pieces of a predetermined size by a cutting machine such as a mincing machine.
  • a cutting machine such as a mincing machine.
  • the placenta is immediately placed in a freezer to freeze (S6: second freezing step). This activates the useful components contained in the placenta and improves its stability.
  • the shredded placenta is placed in a solvent and subjected to decomposition extraction to extract useful components (S7: extraction step).
  • the method for decomposition and extraction include enzymatic decomposition treatment, hydrolysis treatment, acid treatment, freeze-thaw treatment, and the like, and use of enzymatic decomposition treatment is particularly preferable.
  • Hot spring water having a pH of 5.5 to 8.5 is used as the solvent.
  • hot spring water with a pH of 5.5 or more and 8.5 or less the useful components are extracted completely, and the useful components are contained at a higher concentration than when tap water or purified water is used as the solvent. You can get placenta extract.
  • pH of the hot spring water used as the solvent is 5.5 or more and 8.5 or less, pH adjustment becomes unnecessary or easy when the placenta is blended in cosmetics.
  • the extract (placenta extract) obtained in the extraction step S7 is heat sterilized (S8: heat sterilization step), filtered to remove impurities, and the extract is concentrated (S9: filtration step).
  • S8 heat sterilization step
  • filtered to remove impurities the extract is concentrated (S9: filtration step).
  • S9 filtration step
  • addition of antiseptic, inspection, filling, packaging, etc. are performed as appropriate.
  • it can be used as a liquid raw material for placenta extract to be blended in cosmetics, health foods, and the like.
  • freeze-drying or spray-drying the placenta extract after the filtration step S9 it is possible to obtain a powdered raw material of the placenta extract to be blended in cosmetics, health foods, and the like.
  • blending a predetermined amount of the obtained liquid raw material or powder raw material of the placenta extract it is possible to prepare oral products such as cosmetics or health foods containing the placenta extract.
  • the hot spring water used as a solvent for extraction is preferably Yugawara hot spring water, and more preferably weakly alkaline with a pH of 7.5 or more and less than 8.5. Yugawara hot spring water gushes out in and around Yugawara Town, located in the southwestern part of Kanagawa Prefecture. Yugawara hot spring water is colorless and odorless, so it can reduce the effect on color and odor when used in cosmetics, health foods, and the like. Each example using Yugawara hot spring water as a solvent will be described below.
  • Example 1 is a placenta extract produced by the process shown in FIG. 1 using placenta as a raw material.
  • An enzymatic decomposition treatment was used for the decomposition extraction method in the extraction step S7.
  • the pH, spring quality, etc. of the Yugawara hot spring water used are as follows.
  • FIG. 2 is a graph of the results of Table 1.
  • FIG. 2(a) shows free amino acids
  • FIG. 2(b) shows minerals
  • FIG. 2(c) shows peptide molecular weight distribution.
  • Comparative Example 1 is a placenta extract produced in the same process as in Example 1, except that purified water was used as the extraction solvent.
  • Comparative Example 2 is a placenta extract produced in the same process as in Example 1, except that hot spring water from some place in the northern Kanto region was used as the extraction solvent.
  • the pH and quality of hot spring water in Kita Kanto Somewhere are as follows.
  • ⁇ Gush point Somewhere in northern Kanto ⁇ pH: 2.0 ⁇ Spring quality: Acidic/sulfur-containing aluminum-sulfate/chloride hot spring (hydrogen sulfide type) Comparative Example 3 is a placenta extract produced by the same process as in Example 1, except that hot spring water from a certain place in Saitama Prefecture was used as the extraction solvent.
  • the pH and quality of hot spring water in Saitama Prefecture are as follows.
  • ⁇ Gush place Somewhere in Saitama Prefecture ⁇ pH: 8.9 ⁇ Spring quality: Sodium-chloride cold mineral spring
  • Comparing Example 1 (solvent: Yugawara hot spring water) with Comparative Example 1 (solvent: purified water), an increase was confirmed for all amino acids except for glycine. As for minerals, an increase was confirmed in calcium and potassium, which are expected to have cosmetic effects. Regarding the peptide molecular weight, the distribution of molecules with a size of 1,000 or more decreased, and the distribution of molecules with a size of less than 1,000, especially with a size of less than 500, which has high permeability and moisturizing effect, increased. On the other hand, comparing Comparative Example 2 (solvent: North Kanto Somewhere Hot Spring Water) with Comparative Example 1, an increase in calcium and potassium was confirmed for minerals, but a decrease in amino acid components other than proline and cystine.
  • the distribution of molecules with a size of less than 500 increased, but the distribution of molecules with a size of 500 or more and less than 3,000 decreased, and the distribution of molecules with a size of 3,000 or more increased.
  • Comparative Example 3 solvent: hot spring water in a certain place in Saitama Prefecture
  • isoleucine, alanine, tryptophan, and cystine among the amino acids increased. are both small.
  • minerals an increase in calcium was confirmed, but a decrease in potassium.
  • Peptide molecular weights increased in the distribution of molecules with a size of 3,000 or more and decreased in the distribution of molecules with a size of less than 3,000.
  • Yugawara hot spring water as a solvent, it is possible to increase the content of useful ingredients in the placenta extract more than when purified water or other hot spring water is used as a solvent, and the size is less than 1,000. , especially below 500 molecules can be increased.
  • Example 1 Placenta extract using Yugawara hot spring water as a solvent
  • Comparative example 1 Placenta extract using purified water as a solvent
  • Comparative example 4 Yugawara hot spring water Comparative example 5: Purified water [Method] 1.
  • FIG. 3 is a graph showing the results of Skin Moisture Content Test 1
  • FIG. 4 is a graph showing the results of Skin Moisture Content Test 2.
  • the horizontal axis represents time (min), and the vertical axis represents skin moisture content ( ⁇ S), with the normal skin moisture content set to 0.
  • the results of Example 1 are indicated by “ ⁇ and solid line”
  • the results of Comparative Example 1 are indicated by “ ⁇ and long dashed line”
  • the results of Comparative Example 4 are indicated by “ ⁇ and dotted line”
  • Comparative Example 5 The results are indicated by “ ⁇ and short dashed line”.
  • the placenta extract of Example 1 exhibited a higher skin moisture content than each Comparative Example immediately after application, and exhibited a higher skin moisture content than each Comparative Example even 60 minutes after application.
  • the results of Example 1 are indicated by “ ⁇ and solid line”
  • the results of Comparative Example 5 are indicated by “ ⁇ and long dashed line”
  • the results of Comparative Example 6 are indicated by “ ⁇ and short dashed line”.
  • the placenta extract of Example 1 had the same skin moisture content as the placenta extract of Comparative Example 6 until about 10 minutes after application, but the subsequent decrease in skin moisture content was comparable. Compared to Example 6, it was moderate, and even after 60 minutes of application, the skin moisture content was higher than that of each comparative example.
  • the production method of the present invention it is possible to obtain a placenta extract that has a higher content of useful ingredients, an enhanced usefulness to the skin, and an excellent moisturizing effect.
  • placenta such as rhinoceros phlox, amniotic membrane, sake lees, or bird's nest
  • the production method of the present invention can be used to increase the useful ingredients and the moisturizing effect. The following shows the test results when the raw materials were rhinoceros rotunda, amniotic membrane, or sake lees.
  • Example 2 is a rhinoceros rotunda extract produced using rhinoceros rotunda (umbilical cord) as a raw material.
  • the production method is basically the same as the placenta extract production method of Example 1, but does not have the second freezing step S6.
  • Enzymatic decomposition treatment was used as the method of decomposition extraction in the extraction process.
  • the pH and spring quality of the Yugawara hot spring water used are the same as in Example 1.
  • the results of component analysis of the Rhinoceros rotundus extract (Rhinoceros rhinoceros rotunda extract) according to Example 2 are shown in Table 2 below together with the results of component analysis of the Rhinoceros rhinoceros rotundum extract according to Comparative example 7. Moreover, FIG.
  • Comparative Example 7 is a rhinoceros cypress extract produced in the same process as in Example 2, except that purified water was used as the extraction solvent.
  • FIG. 6 is a graph showing the results of Skin Moisture Content Test 3.
  • the horizontal axis represents time (min), and the vertical axis represents skin moisture content ( ⁇ S), with the normal skin moisture content set to 0.
  • the results of Example 2 are indicated by “ ⁇ and solid line”
  • the results of Comparative Example 5 are indicated by “ ⁇ and long dashed line”
  • the results of Comparative Example 8 are indicated by “ ⁇ and short dashed line”.
  • the Rhinoceros magpita extract of Example 2 showed a slower decrease in skin moisture content after 15 minutes of application than each Comparative Example, and even after 60 minutes of application, the skin moisture content was higher than that of each Comparative Example. Moisture content was indicated.
  • Example 3 is an amniotic membrane extract produced using amniotic membrane as the raw material.
  • the production method is basically the same as the placenta extract production method of Example 1, but does not have the second freezing step S6.
  • Enzymatic decomposition treatment was used as the method of decomposition extraction in the extraction process.
  • the pH and spring quality of the Yugawara hot spring water used are the same as in Example 1.
  • the results of component analysis of the amniotic membrane extract (amniotic membrane extract) according to Example 3 are shown in Table 3 below together with the results of component analysis of the amniotic membrane extract according to Comparative Example 9.
  • FIG. 7 is a graph of the results of Table 3, where FIG. 7(a) shows free amino acids, FIG. 7(b) shows minerals, and FIG. 7(c) shows peptide molecular weight distribution.
  • Comparative Example 9 is an amniotic membrane extract produced in the same steps as in Example 3, except that purified water was used as the extraction solvent.
  • Example 3 Amniotic membrane extract using Yugawara hot spring water as a solvent Comparative example 5: Purified water Comparative example 10: A mixture of amniotic membrane extract and Yugawara hot spring water using purified water as a solvent (mixing was performed immediately before the test, the mixing ratio was 1 : 1) [Method] Same as skin moisture content test 2.
  • FIG. 8 is a graph showing the results of Skin Moisture Content Test 4.
  • the horizontal axis represents time (min), and the vertical axis represents skin moisture content ( ⁇ S), with the normal skin moisture content set to 0.
  • the results of Example 3 are indicated by “ ⁇ and solid line”
  • the results of Comparative Example 5 are indicated by “ ⁇ and long dashed line”
  • the results of Comparative Example 10 are indicated by “ ⁇ and short dashed line”.
  • the amniotic membrane extract of Example 3 exhibited a higher skin moisture content than each comparative example immediately after application, and exhibited a higher skin moisture content than each comparative example even 60 minutes after application.
  • Example 4 is a sake lees extract produced using sake lees as the raw material.
  • the sake lees extract of Example 4 was extracted by adding 1,3-butylene glycol to the solvent containing the sake lees and stirring the mixture periodically for a predetermined period of time.
  • the pH and spring quality of Yugawara hot spring water used as a solvent are the same as in Example 1.
  • the results of component analysis of the sake lees extract (sake lees extract) according to Example 4 are shown in Table 4 below together with the results of component analysis of the sake lees extract according to Comparative Example 11.
  • FIG. 9 is a graph of the results of Table 4.
  • FIG. 9(a) is for amino acids
  • FIG. 9(b) is for vitamins
  • FIG. 9(c) is for minerals.
  • Comparative Example 11 is a sake lees extract produced in the same process as in Example 4, except that purified water was used as the extraction solvent.
  • Sake lees is extracted by a different method from placenta-based raw materials such as placenta, and the original protein content is low.
  • the free amino acids in the extract are measured as they are, whereas in the case of sake lees extract, the amino acids are measured after all the proteins in the extract are hydrolyzed. .
  • extracts made from placenta as raw materials only those that function as amino acids are measured, whereas in the case of sake lees extract, they are contained regardless of whether they function as amino acids. The difference is that all amino acids are measured.
  • Example 4 The sake lees extract of Example 4 was subjected to the following tests, and changes in skin moisture increase over time after application were measured to confirm the effect of suppressing evaporation of skin moisture.
  • Skin Moisture Content Test 5 [conditions] Temperature: 25°C Humidity: 31% Measuring device: Skin surface stratum corneum water content measuring device (SKICON-200EX manufactured by Yayoi Co., Ltd.) [sample]
  • Example 4 Sake lees extract using Yugawara hot spring water as the solvent Comparative example 5: Purified water Comparative example 11: Sake lees extract using purified water as the solvent Comparative example 12: Mixture of sake lees extract and Yugawara hot spring water using purified water as the solvent (Mixing is done just before the test, the mixing ratio is 1:1) [Method] Same as skin moisture content test 2.
  • FIG. 10 is a graph showing the results of Skin Moisture Content Test 5.
  • the horizontal axis represents time (min), and the vertical axis represents skin moisture content ( ⁇ S), with the normal skin moisture content set to 0.
  • the results of Example 4 are indicated by “ ⁇ and solid line”
  • the results of Comparative Example 5 are indicated by “ ⁇ and short dashed line”
  • the results of Comparative Example 11 are indicated by “ ⁇ and dotted line”
  • Comparative Example 12 The results are indicated by “ ⁇ and long dashed line”.
  • the sake lees extract of Example 4 exhibited a higher skin moisture content than each comparative example immediately after application, and exhibited a higher skin moisture content than each comparative example even 60 minutes after application.

Abstract

Provided are: a method for producing an extract, in which, in an extraction step for adding a starting material to a solvent to extract a useful component of the starting material, hot-spring water at a pH of 5.5 to 8.5 is used as the solvent to increase the useful component content in the extract compared to conventional methods; and a method for producing a cosmetic and a substance for oral use that contain said extract.

Description

抽出物の製造方法、化粧品の製造方法、及び経口物の製造方法Extract manufacturing method, cosmetic manufacturing method, and oral product manufacturing method
 本発明は、原料を溶媒に入れて有用成分の抽出を行う抽出物の製造方法、及び当該抽出物を配合した化粧品又は経口物の製造方法に関する。 The present invention relates to a method for producing an extract by adding raw materials to a solvent and extracting useful ingredients, and a method for producing cosmetics or oral products containing the extract.
 温泉水は、肌等によい成分が含まれているため、入浴用途のみならず化粧品や健康食品等に配合されることがある。
 例えば、特許文献1には、皮膚保湿能を高めることを目的として、モール温泉水、またはモール温泉水および白鶴霊芝、白鶴霊芝エキスまたは白鶴霊芝エキス末を主成分とする化粧料が開示されている。
 また、特許文献2には、保水力及び保湿力を高めることを目的として、アルカリ性の温泉水と、フェノキシエタノールと、コラーゲンと、エラスチンと、プラセンタエキスと、ペンチレングリコールと、グリセリンと、ブチレングリコールとを混合し、混合液がアルカリ性である基礎化粧水が開示されている。
Hot spring water contains ingredients that are good for the skin, so it is often used not only for bathing but also in cosmetics and health foods.
For example, Patent Document 1 discloses a cosmetic containing Moor hot spring water, Moor hot spring water, Hakutsuru Reishi mushroom, Hakutsuru Reishi extract, or Hakutsuru Reishi extract powder as main ingredients for the purpose of enhancing skin moisturizing ability. It is
In addition, Patent Document 2 discloses that alkaline hot spring water, phenoxyethanol, collagen, elastin, placenta extract, pentylene glycol, glycerin, and butylene glycol are used for the purpose of increasing water retention and moisturizing power. are mixed, and the mixed liquid is alkaline.
 また、哺乳動物特有の臓器であるプラセンタ(胎盤)から抽出したプラセンタエキスには、アミノ酸や酵素類など様々な有用成分が含まれている。そのため、プラセンタエキスは、化粧品や健康食品等の原料として利用されている。同様に、臍帯から抽出したサイタイエキス、羊膜から抽出した羊膜エキス、酒粕から抽出した酒粕エキス、又は燕の巣から抽出した燕の巣エキスも、化粧品や健康食品等の原料として利用されている。
 例えば、特許文献3には、プラセンタエキスを有効成分とする白髪抑制用食品が開示されている。
 また、特許文献4には、プラセンタエキスやサイタイエキスを配合したダイエット食品が開示されている。
 また、特許文献5には、アンチエイジング効果に有用な成分が多く含まれる羊膜由来原料(羊膜エキス)の製造方法が開示されている。
 また、特許文献6には、カルボキシ基含有アニオン性高分子と、ヒドロキシプロピルメチルセルロース又はキサンタンガムである化合物と、美肌成分として酒粕エキスを含むゲル状化粧料が開示されている。
 また、特許文献7には、燕の巣抽出エキスとしてシアル酸が配合されて成るドリンクであって、シアル酸は、燕の巣からエンド型アルカリ性プロテアーゼを分解酵素として用いて加水分解されることにより抽出される抽出エキスとして形成されて飲料溶媒中に含有されていることが開示されている。
Placenta extract extracted from placenta, which is an organ unique to mammals, contains various useful components such as amino acids and enzymes. Therefore, placenta extract is used as a raw material for cosmetics, health foods, and the like. Similarly, Rhinophyte extract extracted from umbilical cord, amniotic membrane extract extracted from amniotic membrane, sake lees extract extracted from sake lees, or bird's nest extract extracted from bird's nest are also used as raw materials for cosmetics, health foods, etc. .
For example, Patent Literature 3 discloses a food for suppressing gray hair containing a placenta extract as an active ingredient.
In addition, Patent Document 4 discloses a diet food containing a placenta extract and a rhinoceros cypress extract.
Further, Patent Document 5 discloses a method for producing an amniotic membrane-derived raw material (amniotic membrane extract) containing many components useful for anti-aging effects.
Further, Patent Document 6 discloses a gel cosmetic containing a carboxy group-containing anionic polymer, a compound of hydroxypropylmethylcellulose or xanthan gum, and sake lees extract as a skin-beautifying ingredient.
In addition, Patent Document 7 discloses a drink containing sialic acid as a bird's nest extract. It is disclosed to be formed as an extract to be extracted and contained in a beverage solvent.
 また、特許文献8には、4-ビニルグアヤコールを配合した飲食品が開示されており、段落0045においては、植物等から4-ビニルグアヤコールを抽出する際の抽出溶媒として使用し得る水の一つに温泉水が挙げられている。
 また、特許文献9には、シャクヤク抽出物を有効成分とするABCA12遺伝子発現促進剤が開示されており、段落0015においては、シャクヤクの抽出溶媒として使用可能な水の一つに温泉水が挙げられている。
In addition, Patent Document 8 discloses food and drink containing 4-vinylguaiacol, and in paragraph 0045, one of the waters that can be used as an extraction solvent when extracting 4-vinylguaiacol from plants etc. hot spring water is mentioned.
In addition, Patent Document 9 discloses an ABCA12 gene expression promoter containing a peony extract as an active ingredient. ing.
特開2000-239146号公報JP-A-2000-239146 特開2012-250960号公報JP 2012-250960 A 特開2019-054769号公報JP 2019-054769 A 特開2006-282609号公報JP 2006-282609 A 特開2018-188401号公報JP 2018-188401 A 特開2019-127460号公報JP 2019-127460 A 特開2019-129803号公報JP 2019-129803 A 特開2020-092719号公報JP 2020-092719 A 特開2020-138932号公報Japanese Patent Application Laid-Open No. 2020-138932
 化粧品、又は健康食品等の経口物に配合する抽出物は、有用成分がより多く含まれていることが望ましい。
 しかし、特許文献1、2のように、抽出後に温泉水を混合して混合物とする場合は、抽出物の濃度が薄まってしまい、混合物に含まれる有用成分の量が必ずしも十分とはいえない場合がある。
 また、特許文献3-7は、温泉水を利用して抽出物に含まれる有用成分の量を高めようとするものではない。
 また、特許文献8、9には、抽出溶媒に温泉水を用いてもよい旨の記載はあるが、あくまで抽出溶媒の一例に過ぎず、温泉水に着目して抽出物に含まれる有用成分の量を高めようとするものではない。
 そこで本発明は、温泉水を利用することにより、抽出物(エキス、抽出溶液)中の有用成分の含有量を従来よりも増加させ、皮膚への有用性を高める抽出物の製造方法、並びに当該抽出物を配合した化粧品及び経口物の製造方法を提供することを目的とする。
It is desirable that extracts to be incorporated into oral products such as cosmetics or health foods contain more useful ingredients.
However, as in Patent Documents 1 and 2, when hot spring water is mixed after extraction to form a mixture, the concentration of the extract is diluted, and the amount of useful ingredients contained in the mixture is not necessarily sufficient. There is
Moreover, Patent Documents 3 to 7 do not attempt to increase the amount of useful components contained in the extract by using hot spring water.
In addition, Patent Documents 8 and 9 state that hot spring water may be used as an extraction solvent, but this is only an example of an extraction solvent, and focusing on hot spring water, the useful components contained in the extract can be extracted. I'm not trying to increase the quantity.
Therefore, the present invention provides a method for producing an extract that uses hot spring water to increase the content of useful components in the extract (extract, extraction solution) compared to the conventional method, thereby enhancing usefulness for the skin, and the method for producing the extract. An object of the present invention is to provide a method for producing cosmetics and oral preparations containing an extract.
 請求項1記載に対応した抽出物の製造方法においては、原料を溶媒に入れて原料の有用成分を抽出する抽出工程において、溶媒としてpH5.5以上8.5以下の温泉水を用いることを特徴とする。
 請求項2記載の本発明は、請求項1に記載の抽出物の製造方法において、原料は、プラセンタ、サイタイ、羊膜、酒粕、又は燕の巣であることを特徴とする。
 請求項3記載の本発明は、請求項1に記載の抽出物の製造方法において、原料は、プラセンタ、サイタイ、又は羊膜であり、抽出工程の前に、原料を凍結する凍結工程と、凍結工程の後に原料を常温下で融解する常温下融解工程と、常温下融解工程の後に原料を洗浄する洗浄工程と、洗浄工程の後に原料を細断するミンチ処理工程とを行うことを特徴とする。
 請求項4記載の本発明は、請求項1から請求項3のいずれか一項に記載の抽出物の製造方法において、温泉水が湯河原温泉水であることを特徴とする。
 請求項5記載の本発明は、請求項4に記載の抽出物の製造方法において、湯河原温泉水は、泉質がナトリウム・カルシウム-塩化物・硫酸塩温泉であり、かつ弱アルカリ性であることを特徴とする。
 請求項6記載に対応した化粧品の製造方法においては、請求項1から請求項5のいずれか一項に記載の抽出物の製造方法で得られた抽出物を配合することを特徴とする。
 請求項7記載に対応した経口物の製造方法においては、請求項1から請求項5のいずれか一項に記載の抽出物の製造方法で得られた抽出物を配合することを特徴とする。
A method for producing an extract corresponding to claim 1 is characterized in that hot spring water having a pH of 5.5 or more and 8.5 or less is used as a solvent in the extraction step of putting the raw material into a solvent and extracting the useful components of the raw material. and
The present invention according to claim 2 is characterized in that, in the method for producing an extract according to claim 1, the raw material is placenta, rhinoceros cypress, amniotic membrane, sake lees, or bird's nest.
The present invention according to claim 3 is the method for producing an extract according to claim 1, wherein the raw material is placenta, rhinoceros cypress, or amniotic membrane, and a freezing step of freezing the raw material before the extraction step; It is characterized by performing a normal temperature melting step of melting the raw material at normal temperature, a washing step of washing the raw material after the normal temperature melting step, and a mincing process of chopping the raw material after the washing step.
According to a fourth aspect of the present invention, in the method for producing an extract according to any one of the first to third aspects, the hot spring water is Yugawara hot spring water.
The present invention according to claim 5 is the method for producing an extract according to claim 4, wherein the Yugawara hot spring water has a sodium/calcium-chloride/sulfate hot spring and is weakly alkaline. Characterized by
A method for producing cosmetics corresponding to claim 6 is characterized in that the extract obtained by the method for producing an extract according to any one of claims 1 to 5 is blended.
A method for producing an oral preparation corresponding to claim 7 is characterized by blending an extract obtained by the method for producing an extract according to any one of claims 1 to 5.
 本発明によれば、抽出物中の有用成分の含有量を従来よりも増加させ、皮膚への有用性を高めることができる。 According to the present invention, the content of useful ingredients in the extract can be increased compared to the past, and the usability for the skin can be enhanced.
本発明の実施形態によるプラセンタ抽出物(プラセンタエキス)の製造工程を示す図A diagram showing a manufacturing process of a placenta extract (placenta extract) according to an embodiment of the present invention. 同プラセンタエキスの成分分析結果を示すグラフGraph showing the results of component analysis of the same placenta extract 同肌水分量試験1の結果を示すグラフGraph showing the results of the same skin moisture content test 1 同肌水分量試験2の結果を示すグラフGraph showing the results of the same skin moisture content test 2 同サイタイ抽出物(サイタイエキス)の成分分析結果を示すグラフGraph showing the results of component analysis of the Rhinoceros rhinoceros extract 同肌水分量試験3の結果を示すグラフGraph showing the results of the same skin moisture content test 3 同羊膜抽出物(羊膜エキス)の成分分析結果を示すグラフGraph showing the component analysis results of the same amniotic membrane extract (amniotic membrane extract) 同肌水分量試験4の結果を示すグラフGraph showing the results of the same skin moisture content test 4 同酒粕抽出物(酒粕エキス)の成分分析結果を示すグラフGraph showing the results of component analysis of the same sake lees extract (sake lees extract) 同肌水分量試験5の結果を示すグラフGraph showing the results of the same skin moisture content test 5
 以下に、本発明の実施形態による抽出物の製造方法、化粧品の製造方法、及び経口物の製造方法について説明する。
 図1はプラセンタ抽出物(プラセンタエキス)の製造工程を示す図である。
 抽出物の原料としては、サイタイ、羊膜、酒粕、又は燕の巣など、様々な動植物由来原料を用いることができるが、ここでは代表して胎盤(プラセンタ)を原料とする場合を説明する。
 まず、満期胎盤を分娩直後に採集する(S1:胎盤採集工程)。採集する胎盤は、ヒト、ブタ、ウマ又はヒツジなどの哺乳類動物のものであればよいが、その中でも安全性に優れ、かつ化粧品及び健康食品の用途に適した健常なブタ又はウマの胎盤とすることが好ましい。
 採集した胎盤は、直ちに凍結する(S2:第一凍結工程)。凍結した胎盤は、所定場所まで輸送し保管する。これにより、採集した胎盤を良好な状態で保管することができる。
 使用時には、凍結している胎盤を常温下で融解する(S3:解凍工程)。解凍した胎盤は、皮膜組織を除去して洗浄し(S4:洗浄工程)、絨毛組織を細断する(S5:ミンチ処理工程)。ミンチ処理工程S5においては、ミンチ機等の裁断機で所定寸法に細断する。
 ミンチ処理工程S5の後、速やかに冷凍庫に入れて胎盤を凍結させる(S6:第二凍結工程)。これにより、胎盤に含まれる有用成分が活性化すると共に安定性が向上する。
Hereinafter, a method for producing an extract, a method for producing a cosmetic, and a method for producing an oral product according to embodiments of the present invention will be described.
FIG. 1 is a diagram showing the manufacturing process of a placenta extract (placenta extract).
As the raw material for the extract, various animal and plant-derived raw materials such as rhinoceros bream, amniotic membrane, sake lees, or bird's nest can be used.
First, a full-term placenta is collected immediately after delivery (S1: placenta collection step). The placentas to be collected may be those of mammals such as humans, pigs, horses or sheep, but healthy pig or horse placentas that are superior in safety and suitable for use in cosmetics and health foods should be selected. is preferred.
The collected placenta is immediately frozen (S2: first freezing step). The frozen placenta is transported to a designated location and stored. As a result, the collected placenta can be stored in good condition.
At the time of use, the frozen placenta is thawed at room temperature (S3: thawing step). The thawed placenta is washed after removing the membrane tissue (S4: washing step), and the villous tissue is chopped (S5: mincing step). In the mincing step S5, the meat is cut into pieces of a predetermined size by a cutting machine such as a mincing machine.
After the mincing step S5, the placenta is immediately placed in a freezer to freeze (S6: second freezing step). This activates the useful components contained in the placenta and improves its stability.
 次に、細断した胎盤を溶媒に入れて分解抽出を行い、有用成分を抽出する(S7:抽出工程)。分解抽出の方法としては、酵素分解処理、加水分解処理、酸処理又は凍結融解等が挙げられるが、酵素分解処理を用いることが特に好ましい。
 溶媒には、pH5.5以上8.5以下の温泉水を用いる。pH5.5以上8.5以下の温泉水を溶媒に用いることにより、有用成分を余すことなく抽出して、溶媒を水道水や精製水とする場合に比べて有用成分が高濃度に含まれたプラセンタエキスを得ることができる。また、溶媒として用いる温泉水のpHがpH5.5以上8.5以下であることで、プラセンタを化粧品に配合する場合に、pH調整が不要又は容易となる。
Next, the shredded placenta is placed in a solvent and subjected to decomposition extraction to extract useful components (S7: extraction step). Examples of the method for decomposition and extraction include enzymatic decomposition treatment, hydrolysis treatment, acid treatment, freeze-thaw treatment, and the like, and use of enzymatic decomposition treatment is particularly preferable.
Hot spring water having a pH of 5.5 to 8.5 is used as the solvent. By using hot spring water with a pH of 5.5 or more and 8.5 or less as a solvent, the useful components are extracted completely, and the useful components are contained at a higher concentration than when tap water or purified water is used as the solvent. You can get placenta extract. Further, when the pH of the hot spring water used as the solvent is 5.5 or more and 8.5 or less, pH adjustment becomes unnecessary or easy when the placenta is blended in cosmetics.
 抽出工程S7で得られた抽出物(プラセンタエキス)は、加熱殺菌し(S8:加熱殺菌工程)、ろ過して不純物を取り除き抽出物を濃縮する(S9:ろ過工程)。ろ過工程S9の後は、防腐剤の添加や、検査・充填・包装等を適宜行う。これにより、化粧品や健康食品等に配合するプラセンタエキスの液体原料とすることができる。
 また、ろ過工程S9の後にプラセンタエキスを凍結乾燥又は噴霧乾燥することにより、化粧品や健康食品等に配合するプラセンタエキスの粉末原料とすることもできる。
 また、得られたプラセンタエキスの液体原料又は粉末原料を所定量配合することにより、プラセンタエキスが配合された化粧品、又は健康食品等の経口物とすることができる。
The extract (placenta extract) obtained in the extraction step S7 is heat sterilized (S8: heat sterilization step), filtered to remove impurities, and the extract is concentrated (S9: filtration step). After the filtration step S9, addition of antiseptic, inspection, filling, packaging, etc. are performed as appropriate. As a result, it can be used as a liquid raw material for placenta extract to be blended in cosmetics, health foods, and the like.
Further, by freeze-drying or spray-drying the placenta extract after the filtration step S9, it is possible to obtain a powdered raw material of the placenta extract to be blended in cosmetics, health foods, and the like.
Moreover, by blending a predetermined amount of the obtained liquid raw material or powder raw material of the placenta extract, it is possible to prepare oral products such as cosmetics or health foods containing the placenta extract.
 抽出時の溶媒として用いる温泉水は、湯河原温泉水であることが好ましく、その中でもpHが7.5以上8.5未満の弱アルカリ性であることがより好ましい。湯河原温泉水は、神奈川県南西部に位置する湯河原町及びその付近一帯で湧出する。湯河原温泉水は、無色無臭の泉質であるため、化粧品や健康食品等に配合する際の色や臭いへの影響を低減できる。
 以下に、湯河原温泉水を溶媒として用いた各実施例について説明する。
The hot spring water used as a solvent for extraction is preferably Yugawara hot spring water, and more preferably weakly alkaline with a pH of 7.5 or more and less than 8.5. Yugawara hot spring water gushes out in and around Yugawara Town, located in the southwestern part of Kanagawa Prefecture. Yugawara hot spring water is colorless and odorless, so it can reduce the effect on color and odor when used in cosmetics, health foods, and the like.
Each example using Yugawara hot spring water as a solvent will be described below.
 実施例1は、原料をプラセンタとし、図1に示す工程により製造したプラセンタエキスである。抽出工程S7における分解抽出の方法には、酵素分解処理を用いた。用いた湯河原温泉水のpHや泉質等は下記の通りである。
・湧出地:神奈川県足柄下郡湯河原町宮上
・pH:8.2
・泉質:ナトリウム・カルシウム-塩化物・硫酸塩温泉(旧泉質名 含石膏-食塩泉)
 実施例1によるプラセンタエキスの成分分析結果を、比較例1~3によるプラセンタエキスの成分分析結果と共に下表1に示す。また、図2は表1の結果をグラフ化したものであり、図2(a)は遊離アミノ酸、図2(b)はミネラル、図2(c)はペプチド分子量分布である。
 比較例1は、抽出溶媒を精製水とした以外は実施例1と同様の工程にて製造したプラセンタエキスである。
 比較例2は、抽出溶媒を北関東某所産の温泉水とした以外は実施例1と同様の工程にて製造したプラセンタエキスである。北関東某所温泉水のpHや泉質等は下記の通りである。
・湧出地:北関東某所
・pH:2.0
・泉質:酸性・含硫黄-アルミニウム-硫酸塩・塩化物温泉(硫化水素型)
 比較例3は、抽出溶媒を埼玉県某所産の温泉水とした以外は実施例1と同様の工程にて製造したプラセンタエキスである。埼玉県某所温泉水のpHや泉質等は下記の通りである。
・湧出地:埼玉県某所
・pH:8.9
・泉質:ナトリウム-塩化物冷鉱泉
Example 1 is a placenta extract produced by the process shown in FIG. 1 using placenta as a raw material. An enzymatic decomposition treatment was used for the decomposition extraction method in the extraction step S7. The pH, spring quality, etc. of the Yugawara hot spring water used are as follows.
・Gush place: Miyakami, Yugawara-cho, Ashigarashimo-gun, Kanagawa Prefecture ・pH: 8.2
・Spring quality: sodium/calcium-chloride/sulfate hot spring (former spring quality name: gypsum-containing salt spring)
The results of component analysis of the placenta extract according to Example 1 are shown in Table 1 below together with the results of component analysis of the placenta extract according to Comparative Examples 1-3. Moreover, FIG. 2 is a graph of the results of Table 1. FIG. 2(a) shows free amino acids, FIG. 2(b) shows minerals, and FIG. 2(c) shows peptide molecular weight distribution.
Comparative Example 1 is a placenta extract produced in the same process as in Example 1, except that purified water was used as the extraction solvent.
Comparative Example 2 is a placenta extract produced in the same process as in Example 1, except that hot spring water from some place in the northern Kanto region was used as the extraction solvent. The pH and quality of hot spring water in Kita Kanto Somewhere are as follows.
・Gush point: Somewhere in northern Kanto ・pH: 2.0
・Spring quality: Acidic/sulfur-containing aluminum-sulfate/chloride hot spring (hydrogen sulfide type)
Comparative Example 3 is a placenta extract produced by the same process as in Example 1, except that hot spring water from a certain place in Saitama Prefecture was used as the extraction solvent. The pH and quality of hot spring water in Saitama Prefecture are as follows.
・Gush place: Somewhere in Saitama Prefecture ・pH: 8.9
・Spring quality: Sodium-chloride cold mineral spring
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000001
 実施例1(溶媒:湯河原温泉水)を比較例1(溶媒:精製水)と対比すると、アミノ酸については、グリシン以外の成分全てで増加が確認された。ミネラルについては、美容効果が期待されるカルシウム及びカリウムで増加が確認された。ペプチド分子量は、サイズ1,000以上の分子分布が減少し、浸透性と保湿効果が高いサイズ1,000未満、特にサイズ500未満の分子分布が増加した。
 一方、比較例2(溶媒:北関東某所温泉水)を比較例1と対比すると、ミネラルについてはカルシウム及びカリウムで増加が確認されたが、アミノ酸については、プロリンとシスチン以外の成分は低下した。ペプチド分子量は、サイズ500未満の分子分布は増加したが、サイズ500以上3,000未満の分子分布が減少し、サイズ3,000以上の分子分布が増加した。
 また、比較例3(溶媒:埼玉県某所温泉水)を比較例1と対比すると、アミノ酸については、イソロイシン、アラニン、トリプトファン、及びシスチンで増加が確認されたが、実施例1と比べると増加量はいずれも小さい。ミネラルについては、カルシウムの増加が確認されたが、カリウムは低下した。ペプチド分子量は、サイズ3,000以上の分子分布が増加し、サイズ3,000未満の分子分布が減少した。
 このように、溶媒に湯河原温泉水を用いることで、精製水や他の温泉水を溶媒に用いる場合よりも、プラセンタエキス中の有用成分の含有量を増加させることができ、かつ、サイズ1,000未満、特に500未満の分子分布を増加させることができる。
Comparing Example 1 (solvent: Yugawara hot spring water) with Comparative Example 1 (solvent: purified water), an increase was confirmed for all amino acids except for glycine. As for minerals, an increase was confirmed in calcium and potassium, which are expected to have cosmetic effects. Regarding the peptide molecular weight, the distribution of molecules with a size of 1,000 or more decreased, and the distribution of molecules with a size of less than 1,000, especially with a size of less than 500, which has high permeability and moisturizing effect, increased.
On the other hand, comparing Comparative Example 2 (solvent: North Kanto Somewhere Hot Spring Water) with Comparative Example 1, an increase in calcium and potassium was confirmed for minerals, but a decrease in amino acid components other than proline and cystine. Regarding the peptide molecular weight, the distribution of molecules with a size of less than 500 increased, but the distribution of molecules with a size of 500 or more and less than 3,000 decreased, and the distribution of molecules with a size of 3,000 or more increased.
Further, when comparing Comparative Example 3 (solvent: hot spring water in a certain place in Saitama Prefecture) with Comparative Example 1, it was confirmed that isoleucine, alanine, tryptophan, and cystine among the amino acids increased. are both small. As for minerals, an increase in calcium was confirmed, but a decrease in potassium. Peptide molecular weights increased in the distribution of molecules with a size of 3,000 or more and decreased in the distribution of molecules with a size of less than 3,000.
In this way, by using Yugawara hot spring water as a solvent, it is possible to increase the content of useful ingredients in the placenta extract more than when purified water or other hot spring water is used as a solvent, and the size is less than 1,000. , especially below 500 molecules can be increased.
 実施例1のプラセンタエキスについて以下の試験を行い、塗布後の時間経過に伴う肌の水分増加量の変化を測定し、肌水分の蒸発抑制効果を確認した。
[肌水分量試験1]
[条件]
 温度:25℃
 湿度:25%
 測定機器:皮表角層水分量測定装置(株式会社ヤヨイ製SKICON-200EX)
[試料]
 実施例1:溶媒を湯河原温泉水としたプラセンタエキス
 比較例1:溶媒を精製水としたプラセンタエキス
 比較例4:湯河原温泉水
 比較例5:精製水
[方法]
 1.油性ペンで縦3.0cm、横2.0cm四方の枠を下腕内側部にしるしを付ける。
 2.石けんで測定ポイントを洗い、30分安静に過ごす。
 3.測定ポイントの通常時の肌水分量を測定する。なお、5回測定して平均値を求める。
 4.試料0.1gを測定部位にとり、指の第二関節部分までを使用し縦・横10回ずつ試料を均一になじませる。
 5.試料塗布後、5、10、15、60分後の肌水分量を測定機器を用いて測定する。
 
[肌水分量試験2]
[条件]
 温度:25℃
 湿度:32%
 測定機器:皮表角層水分量測定装置(株式会社ヤヨイ製SKICON-200EX)
[試料]
 実施例1:溶媒を湯河原温泉水としたプラセンタエキス
 比較例5:精製水
 比較例6:溶媒を精製水としたプラセンタエキスと湯河原温泉水との混合物(混合は試験直前に行い、混合比率は1:1である)
[方法]
 試料塗布後、5、10、15、60分後に加えて30分後も測定した以外は肌水分量試験1と同じ。
The placenta extract of Example 1 was subjected to the following tests, and changes in skin moisture increase over time after application were measured to confirm the effect of suppressing evaporation of skin moisture.
[Skin Moisture Content Test 1]
[conditions]
Temperature: 25°C
Humidity: 25%
Measuring device: Skin surface stratum corneum water content measuring device (SKICON-200EX manufactured by Yayoi Co., Ltd.)
[sample]
Example 1: Placenta extract using Yugawara hot spring water as a solvent Comparative example 1: Placenta extract using purified water as a solvent Comparative example 4: Yugawara hot spring water Comparative example 5: Purified water [Method]
1. Mark a 3.0 cm long by 2.0 cm wide frame on the inside of the lower arm with a permanent marker.
2. Wash the measurement points with soap and rest for 30 minutes.
3. Measure the normal skin moisture content at the measurement point. In addition, it measures 5 times and calculates|requires an average value.
4. Take 0.1 g of the sample on the measurement site, and evenly apply the sample 10 times vertically and horizontally using up to the second joint of the finger.
5. 5, 10, 15, and 60 minutes after application of the sample, the skin moisture content is measured using a measuring instrument.

[Skin Moisture Content Test 2]
[conditions]
Temperature: 25°C
Humidity: 32%
Measuring device: Skin surface stratum corneum water content measuring device (SKICON-200EX manufactured by Yayoi Co., Ltd.)
[sample]
Example 1: Placenta extract using Yugawara hot spring water as a solvent Comparative example 5: Purified water Comparative example 6: A mixture of placenta extract and Yugawara hot spring water using purified water as a solvent (mixing was performed immediately before the test, the mixing ratio was 1 : 1)
[Method]
Same as Skin Moisture Content Test 1 except that measurements were made 5, 10, 15 and 60 minutes after application of the sample, and also 30 minutes after application.
 図3は肌水分量試験1の結果を示すグラフ、図4は肌水分量試験2の結果を示すグラフである。なお、横軸は時間(min)、縦軸は肌水分量(μS)であり、通常時の肌水分量を0としている。
 図3において、実施例1の結果を「●及び実線」で示し、比較例1の結果を「▲及び長破線」で示し、比較例4の結果を「×及び点線」で示し、比較例5の結果を「◆及び短破線」で示している。肌水分量試験1の結果、実施例1のプラセンタエキスは、塗布直後から各比較例よりも高い肌水分量を示し、塗布60分後においても各比較例よりも高い肌水分量を示した。
 図4において、実施例1の結果を「●及び実線」で示し、比較例5の結果を「◆及び長破線」で示し、比較例6の結果を「▲及び短破線」で示している。肌水分量試験2の結果、実施例1のプラセンタエキスは、塗布10分後頃までは比較例6のプラセンタエキスと同程度の肌水分量であったが、その後の肌水分量の低下が比較例6に比べて緩やかであり、塗布60分後においても各比較例よりも高い肌水分量を示した。
FIG. 3 is a graph showing the results of Skin Moisture Content Test 1, and FIG. 4 is a graph showing the results of Skin Moisture Content Test 2. As shown in FIG. The horizontal axis represents time (min), and the vertical axis represents skin moisture content (μS), with the normal skin moisture content set to 0.
In FIG. 3 , the results of Example 1 are indicated by “● and solid line”, the results of Comparative Example 1 are indicated by “▲ and long dashed line”, the results of Comparative Example 4 are indicated by “× and dotted line”, and Comparative Example 5. The results are indicated by “♦ and short dashed line”. As a result of Skin Moisture Content Test 1, the placenta extract of Example 1 exhibited a higher skin moisture content than each Comparative Example immediately after application, and exhibited a higher skin moisture content than each Comparative Example even 60 minutes after application.
In FIG. 4 , the results of Example 1 are indicated by “● and solid line”, the results of Comparative Example 5 are indicated by “♦ and long dashed line”, and the results of Comparative Example 6 are indicated by “▲ and short dashed line”. As a result of the skin moisture content test 2, the placenta extract of Example 1 had the same skin moisture content as the placenta extract of Comparative Example 6 until about 10 minutes after application, but the subsequent decrease in skin moisture content was comparable. Compared to Example 6, it was moderate, and even after 60 minutes of application, the skin moisture content was higher than that of each comparative example.
 このように、本発明の製造方法によれば、有用成分の含有量がより多く、皮膚への有用性を高め、保湿効果にも優れたプラセンタエキスを得ることができる。
 また、プラセンタ以外の例えばサイタイ、羊膜、酒粕、又は燕の巣等を原料とする場合においても、本発明の製造方法を用いることで有用成分を高め、保湿効果も上昇させることができる。以下に、原料をサイタイ、羊膜、又は酒粕とした場合の試験結果を示す。
As described above, according to the production method of the present invention, it is possible to obtain a placenta extract that has a higher content of useful ingredients, an enhanced usefulness to the skin, and an excellent moisturizing effect.
In addition, even when materials other than placenta, such as rhinoceros phlox, amniotic membrane, sake lees, or bird's nest, are used as raw materials, the production method of the present invention can be used to increase the useful ingredients and the moisturizing effect. The following shows the test results when the raw materials were rhinoceros rotunda, amniotic membrane, or sake lees.
 実施例2は、原料をサイタイ(臍帯)として製造したサイタイエキスである。製造方法は、基本的に実施例1のプラセンタエキスの製造方法と同様であるが、第二凍結工程S6は有さない。抽出工程における分解抽出の方法には、酵素分解処理を用いた。用いた湯河原温泉水のpHや泉質等は実施例1と同じである。
 実施例2によるサイタイ抽出物(サイタイエキス)の成分分析結果を、比較例7によるサイタイエキスの成分分析結果と共に下表2に示す。また、図5は表2の結果をグラフ化したものであり、図5(a)はミネラル、図5(b)は多糖類分子量分布である。
 比較例7は、抽出溶媒を精製水とした以外は実施例2と同様の工程にて製造したサイタイエキスである。
Example 2 is a rhinoceros rotunda extract produced using rhinoceros rotunda (umbilical cord) as a raw material. The production method is basically the same as the placenta extract production method of Example 1, but does not have the second freezing step S6. Enzymatic decomposition treatment was used as the method of decomposition extraction in the extraction process. The pH and spring quality of the Yugawara hot spring water used are the same as in Example 1.
The results of component analysis of the Rhinoceros rotundus extract (Rhinoceros rhinoceros rotunda extract) according to Example 2 are shown in Table 2 below together with the results of component analysis of the Rhinoceros rhinoceros rotundum extract according to Comparative example 7. Moreover, FIG. 5 is a graph of the results of Table 2, FIG. 5(a) is the mineral, and FIG. 5(b) is the polysaccharide molecular weight distribution.
Comparative Example 7 is a rhinoceros cypress extract produced in the same process as in Example 2, except that purified water was used as the extraction solvent.
Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000002
 実施例2(溶媒:湯河原温泉水)を比較例7(溶媒:精製水)と対比すると、美容効果が期待されるカルシウムの顕著な増加が確認された。多糖類分子量は、サイズ10,000以上の分子分布が減少し、浸透性と保湿効果が高いサイズ1,000以上10,000未満の分子分布が増加した。
 このように、溶媒に湯河原温泉水を用いることで、精製水を溶媒に用いる場合よりも、サイタイエキス中の有用成分の含有量を増加させることができる。
Comparing Example 2 (solvent: Yugawara hot spring water) with Comparative Example 7 (solvent: purified water), a significant increase in calcium, which is expected to have cosmetic effects, was confirmed. Regarding polysaccharide molecular weight, the distribution of molecules with a size of 10,000 or more decreased, and the distribution of molecules with a size of 1,000 or more and less than 10,000, which has high permeability and moisturizing effect, increased.
Thus, by using Yugawara hot spring water as a solvent, it is possible to increase the content of useful components in the rhinoceros cypress extract as compared with the case where purified water is used as a solvent.
 実施例2のサイタイエキスについて以下の試験を行い、塗布後の時間経過に伴う肌の水分増加量の変化を測定し、肌水分の蒸発抑制効果を確認した。
[肌水分量試験3]
[条件]
 温度:24℃
 湿度:31%
 測定機器:皮表角層水分量測定装置(株式会社ヤヨイ製SKICON-200EX)
[試料]
 実施例2:溶媒を湯河原温泉水としたサイタイエキス
 比較例5:精製水
 比較例8:溶媒を精製水としたサイタイエキスと湯河原温泉水との混合物(混合は試験直前に行い、混合比率は1:1である)
[方法]
 肌水分量試験2と同じ。
The following test was performed on the Rhinoceros californica extract of Example 2, and changes in the increase in skin moisture over time after application were measured to confirm the effect of suppressing evaporation of skin moisture.
[Skin moisture content test 3]
[conditions]
Temperature: 24°C
Humidity: 31%
Measuring device: Skin surface stratum corneum water content measuring device (SKICON-200EX manufactured by Yayoi Co., Ltd.)
[sample]
Example 2: Saitai extract using Yugawara hot spring water as a solvent Comparative example 5: Purified water Comparative example 8: A mixture of Saitai extract and Yugawara hot spring water using purified water as a solvent (mixing was performed immediately before the test, mixing ratio is 1:1)
[Method]
Same as skin moisture content test 2.
 図6は肌水分量試験3の結果を示すグラフである。なお、横軸は時間(min)、縦軸は肌水分量(μS)であり、通常時の肌水分量を0としている。
 図6において、実施例2の結果を「●及び実線」で示し、比較例5の結果を「◆及び長破線」で示し、比較例8の結果を「▲及び短破線」で示している。肌水分量試験3の結果、実施例2のサイタイエキスは、塗布15分以降における肌水分量の低下が各比較例よりも緩やかであり、塗布60分後においても各比較例よりも高い肌水分量を示した。
6 is a graph showing the results of Skin Moisture Content Test 3. FIG. The horizontal axis represents time (min), and the vertical axis represents skin moisture content (μS), with the normal skin moisture content set to 0.
In FIG. 6 , the results of Example 2 are indicated by “● and solid line”, the results of Comparative Example 5 are indicated by “♦ and long dashed line”, and the results of Comparative Example 8 are indicated by “▲ and short dashed line”. As a result of Skin Moisture Content Test 3, the Rhinoceros magpita extract of Example 2 showed a slower decrease in skin moisture content after 15 minutes of application than each Comparative Example, and even after 60 minutes of application, the skin moisture content was higher than that of each Comparative Example. Moisture content was indicated.
 実施例3は、原料を羊膜として製造した羊膜エキスである。製造方法は、基本的に実施例1のプラセンタエキスの製造方法と同様であるが、第二凍結工程S6は有さない。抽出工程における分解抽出の方法には、酵素分解処理を用いた。用いた湯河原温泉水のpHや泉質等は実施例1と同じである。
 実施例3による羊膜抽出物(羊膜エキス)の成分分析結果を、比較例9による羊膜エキスの成分分析結果と共に下表3に示す。また、図7は表3の結果をグラフ化したものであり、図7(a)は遊離アミノ酸、図7(b)はミネラル、図7(c)はペプチド分子量分布である。
 比較例9は、抽出溶媒を精製水とした以外は実施例3と同様の工程にて製造した羊膜エキスである。
Example 3 is an amniotic membrane extract produced using amniotic membrane as the raw material. The production method is basically the same as the placenta extract production method of Example 1, but does not have the second freezing step S6. Enzymatic decomposition treatment was used as the method of decomposition extraction in the extraction process. The pH and spring quality of the Yugawara hot spring water used are the same as in Example 1.
The results of component analysis of the amniotic membrane extract (amniotic membrane extract) according to Example 3 are shown in Table 3 below together with the results of component analysis of the amniotic membrane extract according to Comparative Example 9. Moreover, FIG. 7 is a graph of the results of Table 3, where FIG. 7(a) shows free amino acids, FIG. 7(b) shows minerals, and FIG. 7(c) shows peptide molecular weight distribution.
Comparative Example 9 is an amniotic membrane extract produced in the same steps as in Example 3, except that purified water was used as the extraction solvent.
Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000003
 実施例3(溶媒:湯河原温泉水)を比較例9(溶媒:精製水)と対比すると、アミノ酸については、18種の成分全てで増加が確認された。ミネラルについては、美容効果が期待されるカルシウム、カリウム、及びマグネシウムで増加が確認された。ペプチド分子量は、サイズ1,000~6,000の分子分布が大きく減少し、浸透性と保湿効果が高いサイズ500未満の分子分布が増加した。
 このように、溶媒に湯河原温泉水を用いることで、精製水を溶媒に用いる場合よりも、羊膜エキス中の有用成分の含有量を増加させることができ、かつ、500未満の分子分布を増加させることができる。
Comparing Example 3 (solvent: Yugawara hot spring water) with Comparative Example 9 (solvent: purified water), an increase in all 18 kinds of amino acids was confirmed. As for minerals, an increase was confirmed in calcium, potassium, and magnesium, which are expected to have cosmetic effects. As for the peptide molecular weight, the distribution of molecules with a size of 1,000 to 6,000 decreased significantly, and the distribution of molecules with a size of less than 500, which has high permeability and moisturizing effect, increased.
Thus, by using Yugawara hot spring water as a solvent, it is possible to increase the content of useful components in the amniotic membrane extract and increase the molecular distribution of less than 500 compared to the case of using purified water as a solvent. be able to.
 実施例3の羊膜エキスについて以下の試験を行い、塗布後の時間経過に伴う肌の水分増加量の変化を測定し、肌水分の蒸発抑制効果を確認した。
[肌水分量試験4]
[条件]
 温度:25℃
 湿度:41%
 測定機器:皮表角層水分量測定装置(株式会社ヤヨイ製SKICON-200EX)
[試料]
 実施例3:溶媒を湯河原温泉水とした羊膜エキス
 比較例5:精製水
 比較例10:溶媒を精製水とした羊膜エキスと湯河原温泉水との混合物(混合は試験直前に行い、混合比率は1:1である)
[方法]
 肌水分量試験2と同じ。
The amniotic membrane extract of Example 3 was subjected to the following tests, and changes in skin moisture increase over time after application were measured to confirm the skin moisture evaporation inhibitory effect.
[Skin Moisture Content Test 4]
[conditions]
Temperature: 25°C
Humidity: 41%
Measuring device: Skin surface stratum corneum water content measuring device (SKICON-200EX manufactured by Yayoi Co., Ltd.)
[sample]
Example 3: Amniotic membrane extract using Yugawara hot spring water as a solvent Comparative example 5: Purified water Comparative example 10: A mixture of amniotic membrane extract and Yugawara hot spring water using purified water as a solvent (mixing was performed immediately before the test, the mixing ratio was 1 : 1)
[Method]
Same as skin moisture content test 2.
 図8は肌水分量試験4の結果を示すグラフである。なお、横軸は時間(min)、縦軸は肌水分量(μS)であり、通常時の肌水分量を0としている。
 図8において、実施例3の結果を「●及び実線」で示し、比較例5の結果を「◆及び長破線」で示し、比較例10の結果を「▲及び短破線」で示している。肌水分量試験4の結果、実施例3の羊膜エキスは、塗布直後より各比較例よりも高い肌水分量を示し、塗布60分後においても各比較例よりも高い肌水分量を示した。
8 is a graph showing the results of Skin Moisture Content Test 4. FIG. The horizontal axis represents time (min), and the vertical axis represents skin moisture content (μS), with the normal skin moisture content set to 0.
In FIG. 8 , the results of Example 3 are indicated by “● and solid line”, the results of Comparative Example 5 are indicated by “♦ and long dashed line”, and the results of Comparative Example 10 are indicated by “▲ and short dashed line”. As a result of skin moisture content test 4, the amniotic membrane extract of Example 3 exhibited a higher skin moisture content than each comparative example immediately after application, and exhibited a higher skin moisture content than each comparative example even 60 minutes after application.
 実施例4は、原料を酒粕として製造した酒粕エキスである。実施例4の酒粕エキスは、酒粕を入れた溶媒に1,3-ブチレングリコールを加え、定期的に撹拌しながら所定期間かけて抽出した。溶媒として用いた湯河原温泉水のpHや泉質等は実施例1と同じである。
 実施例4による酒粕抽出物(酒粕エキス)の成分分析結果を、比較例11による酒粕エキスの成分分析結果と共に下表4に示す。また、図9は表4の結果をグラフ化したものであり、図9(a)はアミノ酸、図9(b)はビタミン、図9(c)はミネラルである。
 比較例11は、抽出溶媒を精製水とした以外は実施例4と同様の工程にて製造した酒粕エキスである。
 なお、酒粕は、プラセンタなどの胎盤系の原料とは抽出方法が異なることと、元々のタンパク質の含有量が少ないことから、胎盤系の原料を用いた場合とはアミノ酸の測定方法が異なる。具体的には、胎盤系を原料とするエキスの場合は、エキス中の遊離アミノ酸をそのまま測定するのに対し、酒粕エキスの場合は、エキス中のタンパク質をすべて加水分解したのちにアミノ酸を測定する。また、胎盤系を原料とするエキスの場合は、アミノ酸としての働きを持つもののみを測定しているのに対し、酒粕エキスの場合は、アミノ酸としての機能を持つか否かに関係なく含有するアミノ酸を全て測定するという違いがある。
Example 4 is a sake lees extract produced using sake lees as the raw material. The sake lees extract of Example 4 was extracted by adding 1,3-butylene glycol to the solvent containing the sake lees and stirring the mixture periodically for a predetermined period of time. The pH and spring quality of Yugawara hot spring water used as a solvent are the same as in Example 1.
The results of component analysis of the sake lees extract (sake lees extract) according to Example 4 are shown in Table 4 below together with the results of component analysis of the sake lees extract according to Comparative Example 11. Moreover, FIG. 9 is a graph of the results of Table 4. FIG. 9(a) is for amino acids, FIG. 9(b) is for vitamins, and FIG. 9(c) is for minerals.
Comparative Example 11 is a sake lees extract produced in the same process as in Example 4, except that purified water was used as the extraction solvent.
Sake lees is extracted by a different method from placenta-based raw materials such as placenta, and the original protein content is low. Specifically, in the case of an extract made from a placental system, the free amino acids in the extract are measured as they are, whereas in the case of sake lees extract, the amino acids are measured after all the proteins in the extract are hydrolyzed. . In addition, in the case of extracts made from placenta as raw materials, only those that function as amino acids are measured, whereas in the case of sake lees extract, they are contained regardless of whether they function as amino acids. The difference is that all amino acids are measured.
Figure JPOXMLDOC01-appb-T000004
Figure JPOXMLDOC01-appb-T000004
 実施例4(溶媒:湯河原温泉水)を比較例11(溶媒:精製水)と対比すると、アミノ酸については、18種のうち11種で増加が確認された。ミネラルについては、美容効果が期待されるカルシウム及びカリウムで増加が確認された。ビタミンは、美容効果が期待されるビタミンB6及びナイアシンで増加が確認された。
 このように、溶媒に湯河原温泉水を用いることで、精製水を溶媒に用いる場合よりも、酒粕エキス中の有用成分の含有量を増加させることができる。
Comparing Example 4 (solvent: Yugawara hot spring water) with Comparative Example 11 (solvent: purified water), an increase was confirmed in 11 out of 18 amino acids. As for minerals, an increase was confirmed in calcium and potassium, which are expected to have cosmetic effects. As for vitamins, an increase was confirmed in vitamin B6 and niacin, which are expected to have cosmetic effects.
By using Yugawara hot spring water as a solvent in this manner, the content of useful components in the sake lees extract can be increased more than when purified water is used as a solvent.
 実施例4の酒粕エキスについて以下の試験を行い、塗布後の時間経過に伴う肌の水分増加量の変化を測定し、肌水分の蒸発抑制効果を確認した。
[肌水分量試験5]
[条件]
 温度:25℃
 湿度:31%
 測定機器:皮表角層水分量測定装置(株式会社ヤヨイ製SKICON-200EX)
[試料]
 実施例4:溶媒を湯河原温泉水とした酒粕エキス
 比較例5:精製水
 比較例11:溶媒を精製水とした酒粕エキス
 比較例12:溶媒を精製水とした酒粕エキスと湯河原温泉水との混合物(混合は試験直前に行い、混合比率は1:1である)
[方法]
 肌水分量試験2と同じ。
The sake lees extract of Example 4 was subjected to the following tests, and changes in skin moisture increase over time after application were measured to confirm the effect of suppressing evaporation of skin moisture.
[Skin Moisture Content Test 5]
[conditions]
Temperature: 25°C
Humidity: 31%
Measuring device: Skin surface stratum corneum water content measuring device (SKICON-200EX manufactured by Yayoi Co., Ltd.)
[sample]
Example 4: Sake lees extract using Yugawara hot spring water as the solvent Comparative example 5: Purified water Comparative example 11: Sake lees extract using purified water as the solvent Comparative example 12: Mixture of sake lees extract and Yugawara hot spring water using purified water as the solvent (Mixing is done just before the test, the mixing ratio is 1:1)
[Method]
Same as skin moisture content test 2.
 図10は肌水分量試験5の結果を示すグラフである。なお、横軸は時間(min)、縦軸は肌水分量(μS)であり、通常時の肌水分量を0としている。
 図10において、実施例4の結果を「●及び実線」で示し、比較例5の結果を「◆及び短破線」で示し、比較例11の結果を「×及び点線」で示し、比較例12の結果を「▲及び長破線」で示している。肌水分量試験5の結果、実施例4の酒粕エキスは、塗布直後より各比較例よりも高い肌水分量を示し、塗布60分後においても各比較例よりも高い肌水分量を示した。
10 is a graph showing the results of Skin Moisture Content Test 5. FIG. The horizontal axis represents time (min), and the vertical axis represents skin moisture content (μS), with the normal skin moisture content set to 0.
In FIG. 10 , the results of Example 4 are indicated by “● and solid line”, the results of Comparative Example 5 are indicated by “◆ and short dashed line”, the results of Comparative Example 11 are indicated by “× and dotted line”, and Comparative Example 12. The results are indicated by “▲ and long dashed line”. As a result of skin moisture content test 5, the sake lees extract of Example 4 exhibited a higher skin moisture content than each comparative example immediately after application, and exhibited a higher skin moisture content than each comparative example even 60 minutes after application.
S1 胎盤採集工程
S2 第一凍結工程(凍結工程)
S3 解凍工程
S4 洗浄工程
S5 ミンチ処理工程
S6 第二凍結工程(凍結工程)
S7 抽出工程
S8 加熱殺菌工程
S9 ろ過工程
S1 placenta collection step S2 first freezing step (freezing step)
S3 Thawing step S4 Washing step S5 Mincing step S6 Second freezing step (freezing step)
S7 Extraction step S8 Heat sterilization step S9 Filtration step

Claims (7)

  1.  原料を溶媒に入れて前記原料の有用成分を抽出する抽出工程において、前記溶媒としてpH5.5以上8.5以下の温泉水を用いることを特徴とする抽出物の製造方法。 A method for producing an extract, wherein hot spring water having a pH of 5.5 or more and 8.5 or less is used as the solvent in the extraction step of putting the raw material into a solvent and extracting the useful components of the raw material.
  2.  前記原料は、プラセンタ、サイタイ、羊膜、酒粕、又は燕の巣であることを特徴とする請求項1に記載の抽出物の製造方法。  The method for producing the extract according to claim 1, wherein the raw material is placenta, rhinoceros cypress, amniotic membrane, sake lees, or bird's nest.
  3.  前記原料は、プラセンタ、サイタイ、又は羊膜であり、
    前記抽出工程の前に、
    前記原料を凍結する凍結工程と、
    前記凍結工程の後に前記原料を常温下で融解する常温下融解工程と、
    前記常温下融解工程の後に前記原料を洗浄する洗浄工程と、
    前記洗浄工程の後に前記原料を細断するミンチ処理工程と、を行うことを特徴とする請求項1に記載の抽出物の製造方法。
    The raw material is placenta, rhinoceros tie, or amniotic membrane,
    Before the extraction step,
    a freezing step of freezing the raw material;
    A room temperature melting step of melting the raw material at room temperature after the freezing step;
    a washing step of washing the raw material after the step of melting at room temperature;
    2. The method for producing an extract according to claim 1, further comprising performing a mincing step of shredding the raw material after the washing step.
  4.  前記温泉水が湯河原温泉水であることを特徴とする請求項1から請求項3のいずれか一項に記載の抽出物の製造方法。 The method for producing the extract according to any one of claims 1 to 3, wherein the hot spring water is Yugawara hot spring water.
  5.  前記湯河原温泉水は、泉質がナトリウム・カルシウム-塩化物・硫酸塩温泉であり、かつ弱アルカリ性であることを特徴とする請求項4に記載の抽出物の製造方法。 The method for producing an extract according to claim 4, wherein the Yugawara hot spring water has a sodium/calcium-chloride/sulfate hot spring and is weakly alkaline.
  6.  請求項1から請求項5のいずれか一項に記載の抽出物の製造方法で得られた抽出物を配合することを特徴とする化粧品の製造方法。 A method for producing cosmetics, characterized by blending the extract obtained by the method for producing an extract according to any one of claims 1 to 5.
  7.  請求項1から請求項5のいずれか一項に記載の抽出物の製造方法で得られた抽出物を配合することを特徴とする経口物の製造方法。 A method for producing an oral preparation, characterized by blending the extract obtained by the method for producing an extract according to any one of claims 1 to 5.
PCT/JP2022/040577 2022-01-07 2022-10-31 Method for producing extract, method for producing cosmetic, and method for producing substance for oral use WO2023132120A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022-001405 2022-01-07
JP2022001405A JP2023101072A (en) 2022-01-07 2022-01-07 Method for producing extract, method for producing cosmetic, and method for producing substance for oral use

Publications (1)

Publication Number Publication Date
WO2023132120A1 true WO2023132120A1 (en) 2023-07-13

Family

ID=87073411

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2022/040577 WO2023132120A1 (en) 2022-01-07 2022-10-31 Method for producing extract, method for producing cosmetic, and method for producing substance for oral use

Country Status (3)

Country Link
JP (1) JP2023101072A (en)
TW (1) TW202329993A (en)
WO (1) WO2023132120A1 (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58177918A (en) * 1982-04-08 1983-10-18 Ichimaru Fuarukosu Kk Inhibitor for melanin formation by placental decomposition product
JPH10182411A (en) * 1996-12-26 1998-07-07 Kose Corp Preparation for external use for skin
JP2007175685A (en) * 2005-12-26 2007-07-12 Nichihara Research & Development Laboratories Inc Sericin extractor
JP2009165452A (en) * 2008-01-11 2009-07-30 Hiroshi Motomura Pectin extraction method and pectin
JP2014520843A (en) * 2011-07-11 2014-08-25 チャバイオ&ディオステック カンパニー,リミテッド Umbilical cord extract manufacturing method and use thereof
JP2018188401A (en) * 2017-05-10 2018-11-29 株式会社ホルス Method for producing amniotic membrane-derived raw material, method for producing cosmetic product, and method for producing health food
JP2020172468A (en) * 2019-04-11 2020-10-22 国立大学法人秋田大学 Molecular chaperone inducer

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58177918A (en) * 1982-04-08 1983-10-18 Ichimaru Fuarukosu Kk Inhibitor for melanin formation by placental decomposition product
JPH10182411A (en) * 1996-12-26 1998-07-07 Kose Corp Preparation for external use for skin
JP2007175685A (en) * 2005-12-26 2007-07-12 Nichihara Research & Development Laboratories Inc Sericin extractor
JP2009165452A (en) * 2008-01-11 2009-07-30 Hiroshi Motomura Pectin extraction method and pectin
JP2014520843A (en) * 2011-07-11 2014-08-25 チャバイオ&ディオステック カンパニー,リミテッド Umbilical cord extract manufacturing method and use thereof
JP2018188401A (en) * 2017-05-10 2018-11-29 株式会社ホルス Method for producing amniotic membrane-derived raw material, method for producing cosmetic product, and method for producing health food
JP2020172468A (en) * 2019-04-11 2020-10-22 国立大学法人秋田大学 Molecular chaperone inducer

Also Published As

Publication number Publication date
JP2023101072A (en) 2023-07-20
TW202329993A (en) 2023-08-01

Similar Documents

Publication Publication Date Title
JP2021014463A (en) Aquatic animal cartilage extracts
JP5905188B2 (en) Cosmetic or hair restorer containing sialic acid and EGF and / or FGF and method for producing them
AU2004270008B2 (en) Cosmetic composition comprising camel milk
JP2009234980A (en) Cosmetic composition incorporating cell growth factor blended with neuraminic acids and placenta
KR20080063711A (en) Composition of collagen peptides for cosmetics and method thereof
CN105769725A (en) Rosemary moisturizing water and making method thereof
JP2008110927A (en) Cosmetic containing royal jelly protein hydrolyzate
KR100827389B1 (en) Composition of collagen peptides for food and method thereof
EP1317274B1 (en) Peptide composition for treatment of periodontal diseases and prevention of skin aging
KR101489916B1 (en) A method for extracting high purity collagen from animal byproducts
KR101339423B1 (en) cosmetic composition having collagen derived from fishes and manufacturing method thereof
JP2006151847A (en) Collagen peptide composition, method for producing the same and cosmetic composition
JP2013001664A (en) Water-soluble collagen for cosmetic, and cosmetic containing the collagen
WO2018207810A1 (en) Method for producing amnion-derived raw material, method for producing cosmetic, and method for producing health food
KR20130099104A (en) Skin collagen production-promoting agent
WO2023132120A1 (en) Method for producing extract, method for producing cosmetic, and method for producing substance for oral use
KR101645238B1 (en) Cosmetic composition for anti-wrinkle or elasticity of skin
Tarigan et al. Extraction Of Functionally Active Collagen From Salmon Fish As Formulation Of Clay Mask
KR101618726B1 (en) Method for making protein from Pollock skin
KR101609217B1 (en) Method for making glycoprotein from jelly fish and cosmetics containing the same
JPWO2009057282A1 (en) Food material for suppressing bone resorption
JP3172599B2 (en) Cell activator
JP2013234147A (en) Cosmetic composition and method for producing the same
CN116440024B (en) Sea collagen acne-removing repair cream from sea cucumber
JP5783484B2 (en) Skin collagen production promoter

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22918709

Country of ref document: EP

Kind code of ref document: A1